Riskpilot← Back to searchSign inGet full accessFRU MED SMED AS
ASIn liquidationOrg 917395713Maridalsveien 105, 0461 OsloManufacture of jewellery and related articles · NACE 3212Est. 20160 employees
Revenue 2025
NOK 8K
+65% vs 2024
EBITDA margin
-233.7%
+83% vs 2024
Equity ratio
-102.4%
Financial strength
Net profit 2025
NOK -42K
+70% vs 2024
| Revenue | NOK 8K | +65% |
| EBITDA | NOK -19K | +83% |
| Net profit | NOK -42K | +70% |
| Total assets | NOK 46K | -57% |
| Equity | NOK -47K | -788% |
| Employees | 0 | — |
Legal name
FRU MED SMED AS
Org number
917395713
Legal form
Aksjeselskap
NACE code
3212 · Manufacture of jewellery and related articles
Founded
30. juni 2016
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap styrets medlemmer hver for seg styrets leder og ett styremedlem i fellesskap styrets leder alene daglig leder og styrets leder i fellesskap
Company purpose
Produksjon, design og salg av sølvvarer og annet metallarbeid. Grafisk design. Prosjektledelse. Scenekunst.
Address
Maridalsveien 105, 0461 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52 | 91 | 126 | 206 | 146 | 293 | 396 | 47 | 5 | 8 |
| Staff expenses | −1 | −1 | −1 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −42 | 50 | 33 | 152 | −16 | 71 | 309 | −34 | −117 | −19 |
| Depreciation & amort. | −8 | −15 | −15 | −15 | −15 | −15 | −19 | −26 | −26 | −23 |
| EBIT | −50 | 34 | 18 | 137 | −31 | 56 | 290 | −60 | −143 | −42 |
| Net financials | 0 | 0 | 0 | 1 | −0 | −0 | 0 | 3 | 2 | 0 |
| Profit before tax | −50 | 35 | 18 | 138 | −31 | 56 | 290 | −57 | −141 | −42 |
| Tax | −0 | −0 | 1 | 30 | −7 | 6 | 64 | −7 | −0 | −0 |
| Net profit | −50 | 35 | 17 | 108 | −24 | 50 | 226 | −50 | −141 | −42 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 208 | 261 | 184 | 205 | 153 | 241 | 497 | 258 | 107 | 46 |
| Equity | −26 | 9 | 26 | 134 | 110 | 59 | 185 | 135 | −5 | −47 |
| Long-term debt | 40 | 197 | 158 | 10 | 3 | 7 | 6 | 0 | 0 | 0 |
| Short-term debt | 194 | 56 | 1 | 61 | 41 | 175 | 306 | 123 | 112 | 93 |
| Total debt | 234 | 253 | 159 | 71 | 44 | 182 | 312 | 123 | 112 | 93 |
EBITDA margin
-233.7%
This company
15.8%
Market median
-1579% vs market
20162025
Equity ratio
-102.4%
This company
38.2%
Market median
-368% vs market
20162025
Return on equity
-4177100.0%
This company
18.4%
Market median
-22701730% vs market
20162025
Net profit margin
-507.7%
This company
8.1%
Market median
-6368% vs market
20162025
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20162025
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
20162025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-06-07 – 2016-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FRU MED SMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gunnar Eriksson | Board of Directors | 0 companies |
| Catherine Anne Haanes | Chairman | 0 companies |